Catalyst Pharmaceutical CPRX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's pre-tax income?
- Catalyst Pharmaceutical (CPRX) reported pre-tax income of $84.23M in Q1 2026.
- How has Catalyst Pharmaceutical's pre-tax income changed year-over-year?
- Catalyst Pharmaceutical's pre-tax income increased by 18.2% year-over-year, from $71.29M to $84.23M.
- What is the long-term trend for Catalyst Pharmaceutical's pre-tax income?
- Over 4 years (2021 to 2025), Catalyst Pharmaceutical's pre-tax income has grown at a 52.3% compound annual growth rate (CAGR), from $52.67M to $283.52M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.